HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Japan
2025-003895
Filed on 2025-01-10
2025-003895
Filed on 2025-01-10
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
Japan
2024-192788
Filed on 2024-11-01
2024-192788
Filed on 2024-11-01
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
European Patent
19827967.1
Filed on 2021-06-17
19827967.1
Filed on 2021-06-17
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
China
201980090184.6
Filed on 2021-07-23
201980090184.6
Filed on 2021-07-23
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
Japan
2021-531048
Filed on 2019-11-27
2021-531048
Filed on 2019-11-27
Thalidomide Analogs and Methods of Use
United Kingdom
16782148.7
Filed on 2016-09-29
16782148.7
Filed on 2016-09-29
Thalidomide Analogs and Methods of Use
Germany
16782148.7
Filed on 2016-09-29
16782148.7
Filed on 2016-09-29
Thalidomide Analogs and Methods of Use
France
16782148.7
Filed on 2016-09-29
16782148.7
Filed on 2016-09-29
METHODS AND MATERIALS FOR LARGE-SCALE ASSESSMENT OF LIGAND BINDING SELECTIVITY OF G-QUADRUPLEX RECOGNITION USING CUSTOM G4 MICROARRAYS
US Application 18/648,173
Filed on 2024-04-26
Filed on 2024-04-26
CD25-SPECIFIC ANTIBODIES AND USES THEREOF
European Patent
23745029.1
Filed on 2025-01-14
23745029.1
Filed on 2025-01-14